CVS Health Management
Management criteria checks 3/4
CVS Health's CEO is Karen Lynch, appointed in Feb 2021, has a tenure of 3.17 years. total yearly compensation is $21.62M, comprised of 6.9% salary and 93.1% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth $35.12M. The average tenure of the management team and the board of directors is 2.1 years and 6.2 years respectively.
Key information
Karen Lynch
Chief executive officer
US$21.6m
Total compensation
| CEO salary percentage | 6.9% |
| CEO tenure | 3.2yrs |
| CEO ownership | 0.04% |
| Management average tenure | 2.1yrs |
| Board average tenure | 6.2yrs |
Recent management updates
Recent updates
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14
CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07CVS Health: Not One Dividend Cut In 30 Years And A Good Upside
Nov 27CVS Health: All Eyes On December Investor Day
Nov 21CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work
Oct 26CVS Health: 'Only' A Fair Company For A Wonderful Price?
Oct 20CVS Health Offers Recession-Resistant Growth With Transformation
Oct 05CVS Stock: The Risk-Reward Is In A Better Place
Sep 18CVS Health: Share Price Suffers As Business Transformation Flounders
Aug 25Is CVS Health (NYSE:CVS) A Risky Investment?
Aug 25Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation
Aug 16CVS Health: Second Quarter Was Only Decent, But Integration Is On Track
Aug 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$22m | US$2m | US$8b |
| Sep 30 2023 | n/a | n/a | US$8b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$21m | US$1m | US$4b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$8b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$20m | US$1m | US$8b |
| Sep 30 2021 | n/a | n/a | US$8b |
| Jun 30 2021 | n/a | n/a | US$7b |
| Mar 31 2021 | n/a | n/a | US$7b |
| Dec 31 2020 | US$11m | US$1m | US$7b |
Compensation vs Market: Karen's total compensation ($USD21.62M) is above average for companies of similar size in the US market ($USD13.41M).
Compensation vs Earnings: Karen's compensation has been consistent with company performance over the past year.
CEO
Karen Lynch (60 yo)
3.2yrs
Tenure
US$21,615,034
Compensation
Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.2yrs | US$21.62m | 0.040% $ 35.1m | |
| Executive VP & CFO | less than a year | US$4.58m | 0.0028% $ 2.5m | |
| Executive VP of Ventures and Chief Digital | 1.8yrs | US$8.88m | 0.0016% $ 1.4m | |
| Executive VP | 1.2yrs | US$11.89m | 0.00077% $ 673.5k | |
| Executive VP | 2.4yrs | US$8.58m | 0.0037% $ 3.2m | |
| Senior Director of Business Development & CVS Health and Partner & Co-Founder | no data | no data | no data | |
| Senior VP | 5.4yrs | no data | 0.00067% $ 586.0k | |
| Senior Vice President of Business Development & Investor Relations | 1.8yrs | no data | no data | |
| Executive VP & Chief Compliance Officer | no data | no data | no data | |
| Executive VP & Chief People Officer | 3.2yrs | no data | 0.0030% $ 2.6m | |
| Executive Vice President & President of CVS Caremark | 1.3yrs | no data | 0.0032% $ 2.8m | |
| Executive VP and Chief Customer & Experience Officer | 3.3yrs | no data | 0.0099% $ 8.6m |
2.1yrs
Average Tenure
58yo
Average Age
Experienced Management: CVS's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.2yrs | US$21.62m | 0.040% $ 35.1m | |
| Independent Director | less than a year | US$195.42k | 0.00022% $ 192.4k | |
| Independent Director | 5.4yrs | US$314.00k | 0.0025% $ 2.2m | |
| Independent Chairman | 5.4yrs | US$576.50k | 0.00033% $ 288.6k | |
| Independent Director | 6.9yrs | US$301.50k | 0.00094% $ 822.2k | |
| Independent Director | 10.6yrs | US$321.50k | 0.0023% $ 2.0m | |
| Independent Director | 13.3yrs | US$321.50k | 0.0026% $ 2.2m | |
| Independent Director | 17.1yrs | US$321.50k | 0.0095% $ 8.3m | |
| Independent Director | 17.1yrs | US$321.50k | 0.0085% $ 7.5m | |
| Independent Director | 9.1yrs | US$301.50k | 0.00024% $ 209.9k | |
| Independent Director | 5.4yrs | US$318.17k | 0.0026% $ 2.3m | |
| Independent Director | 1.6yrs | US$301.50k | 0.00040% $ 349.9k |
6.2yrs
Average Tenure
67.5yo
Average Age
Experienced Board: CVS's board of directors are considered experienced (6.2 years average tenure).